News on technologies and applications for point-of-care testing.
Talis, a point-of-care test developer, said that the principal purpose for the offering is to obtain additional capital to support its operations, among other purposes.
The company has developed an analyzer to run PCR, immunochemistry, and cytometry tests at the same time for a variety of diseases including COVID-19.
FIND said it will announce agreements that will enable the distribution of more than 250 million rapid antigen tests per year to low- and middle-income countries.
NASA increasingly believes the platform could be used in the medical arena.
The firm has collaborated with Novartis to help pilot the new sickle cell disease test and a treatment in Ghana.
